A5065299206- Ovarian function and disorders
- Reproductive Biology and Fertility
- Assisted Reproductive Technology and Twin Pregnancy
- Reproductive System and Pregnancy
- Reproductive Health and Technologies
- Hormonal and reproductive studies
- Reproductive Physiology in Livestock
- Hypothalamic control of reproductive hormones
- Body Image and Dysmorphia Studies
- Pregnancy and preeclampsia studies
Hospital de Sant Pau
2021-2023
Puigvert Foundation
2021-2023
Hospital Universitario Dexeus
2017-2021
A retrospective cohort study was performed to examine whether, in artificial endometrial preparation for frozen embryo transfer (FET) cycles, progesterone (P) levels the day prior of euploid embryos have an impact on pregnancy outcomes. In a private university clinic, 244 FETs between January 2016 and June 2017 were analyzed. Endometrial achieved with estradiol valerate vaginal micronized progesterone. Serum P measured. multivariable analysis assess relationship serum level outcomes...
Abstract STUDY QUESTION Does an individualised luteal phase support (iLPS), according to serum progesterone (P4) level the day prior euploid frozen embryo transfer (FET), improve pregnancy outcomes when started on previous transfer? SUMMARY ANSWER Patients with low P4 FET can benefit from addition of daily subcutaneous injections (Psc), FET, and achieve similar reproductive compared those initial adequate levels. WHAT IS KNOWN ALREADY The ratio between FET/IVF has spectacularly increased in...
Abstract STUDY QUESTION Are progesterone (P) levels on the day before natural cycle frozen embryo transfer (NC-FET) associated with live birth rate (LBR)? SUMMARY ANSWER Regular ovulatory women undergoing NC-FET serum P <10 ng/ml blastocyst have a significantly lower LBR than those >10 ng/ml. WHAT IS KNOWN ALREADY The importance of around time in patients FET under artificial endometrial preparation has been well established. However, no study analyzed true cycle. DESIGN, SIZE,...
Abstract Study question What are the perspectives regarding sperm donor anonymity among Spanish recipients? Summary answer 56.6% of patients who undergo treatment with donated in a population would like to choose between type anonymity. is known already Spain one few European countries that still maintains main gamete provider for all countries. Among other reasons (cross border legislation, limitations countries, etc.), Society Fertility defend their donors reason such high demand from as...